"Super-Spreaders" and Person-to-Person Transmission of Andes Virus in Argentina
Open accessAbstract
BACKGROUND: From November 2018 through February 2019, person-to-person transmission of Andes virus (ANDV) hantavirus pulmonary syndrome occurred in Chubut Province, Argentina, and resulted in 34 confirmed infections and 11 deaths. Understanding the genomic, epidemiologic, and clinical characteristics of person-to-person transmission of ANDV is crucial to designing effective interventions. METHODS: Clinical and epidemiologic information was obtained by means of patient report and from public health centers. Serologic testing, contact-tracing, and next-generation sequencing were used to identify ANDV infection as the cause of this outbreak of hantavirus pulmonary syndrome and to reconstruct person-to-person transmission events. RESULTS: After a single introduction of ANDV from a rodent reservoir into the human population, transmission was driven by 3 symptomatic persons who attended crowded social events. After 18 cases were confirmed, public health officials enforced isolation of persons with confirmed cases and self-quarantine of possible contacts; these measures most likely curtailed further spread. The median reproductive number (the number of secondary cases caused by an infected person during the infectious period) was 2.12 before the control measures were enforced and decreased to 0.96 after the measures were implemented. Full genome sequencing of the ANDV strain involved in this outbreak was performed with specimens from 27 patients and showed that the strain that was present (Epuyén/18-19) was similar to the causative strain (Epilink/96) in the first known person-to-person transmission of hantavirus pulmonary syndrome caused by ANDV, which occurred in El Bolsón, Argentina, in 1996. Clinical investigations involving patients with ANDV hantavirus pulmonary syndrome in this outbreak revealed that patients with a high viral load and liver injury were more likely than other patients to spread infection. Disease severity, genomic diversity, age, and time spent in the hospital had no clear association with secondary transmission. CONCLUSIONS: Among patients with ANDV hantavirus pulmonary syndrome, high viral titers in combination with attendance at massive social gatherings or extensive contact among persons were associated with a higher likelihood of transmission. (Funded by the Ministerio de Salud y Desarrollo Social de la Nación Argentina and others.).
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
6 of 21 cited sources checked · 1 supported · 0 flagged · accuracy not yet measured
- Premisecitation§ H
An important known risk factor for person-to-person transmission of ANDV is prolonged or close contact with symptomatic persons.
“An important known risk factor for person-to-person transmission of ANDV is prolonged or close contact with symptomatic persons.17,18,21”
Quote in the paperNot a substantial claim2 of 3 sources checked- cites [17] 17. Ferrés M, Vial P, Marco C, et al. Pro- spective evaluation of household contacts of persons with hantavirus cardiopulmo- The New England Journal of Medicine Downloaded from nejm.org on August 29, 2023. For personal use only. No other uses without permission. Copyright © 2020 Massachusetts Medical Society. All rights reserved. n engl j med 383;23 nejm.org December 3, 2020 nary syndrome in Chile. J Infect Dis 2007; 195: 1563-71. source
- cites [18] 18. Lázaro ME, Cantoni GE, Calanni LM, et al. Clusters of hantavirus infection, southern Argentina. Emerg Infect Dis 2007; 13: 104-10. source
The Discussion says close and prolonged contact may be necessary for person-to-person transmission of Andes virus, particularly during the early phase of illness. That supports the importance of contact with an infected person, but the claim presents a tentative, combined condition as an established risk factor involving either close or prolonged contact. (LLM, conf=0.83)
Experimental — accuracy not yet measured - cites [21] 21. World Health Organization. Hanta- virus pulmonary syndrome -Argentine Republic. 2019 (https://www . who . int/ csr/ don/ 23 -January -2019 -hantavirus -argentina/ en/ ).
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationcitation§ Discussion
The ANDV Epuyén/18-19 strain shows a facility (R>2) for sustaining continuous chains of transmission if no control measures are enforced.
“The super-spreading capability of the ANDV Epuyén/18-19 strain shows a facility (R>2) for sustaining continuous chains of transmission if no control measures are enforced.39”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [39] 39. Geoghegan JL, Holmes EC. Predicting virus emergence amid evolutionary noise. Open Biol 2017; 7: 170189. source
The nature of virus emergence section discusses sustained transmission in other viruses, while the population-genetic framework section discusses transmission in general; neither addresses the ANDV Epuyén/18-19 strain. Searches for ANDV, Epuyén, R>2, and transmission without control measures found no passage supporting the strain-specific claim. (LLM, conf=0.76)
Experimental — accuracy not yet measured
- Findingown data§ Abstract
Clinical investigations involving patients with ANDV hantavirus pulmonary syndrome in this outbreak revealed that patients with a high viral load and liver injury were more likely than other patients to spread infection.
“Clinical investigations involving patients with ANDV hantavirus pulmonary syndrome in this outbreak revealed that patients with a high viral load and liver injury were more likely than other patients to spread infection.”
Quote in the paperSubstantial claim - Findingown data§ Phylogenetic, Genomic, and Immunologic Analyses
RNA belonging to the S segment of the viral genome of ANDV was detected by RT-qPCR in all blood specimens.
“RNA belonging to the S segment of the viral genome of ANDV was detected by RT-qPCR in all blood specimens (Table 1 and Supplementary Appendix 2).”
Quote in the paperNot a substantial claim - Findingown data§ Epidemiologic Analysis
Incubation periods ranged from 9 to 40 days.
“Incubation periods ranged from 9 to 40 days.”
Quote in the paperNot a substantial claim
- Findingown data§ Clinical Characteristics
No significant differences or associations were found between disease severity and Z value (P>0.05).
“No significant differences or associations were found between disease severity and Z value (P>0.05)(Supplementary Appendix 3).”
Quote in the paperNot a substantial claim - Findingown data§ Epidemiologic Analysis
An additional 10 persons who attended the wake and were in close contact with Patient 9 became ill between 14 and 40 days after the wake for Patient 2.
“An additional 10 persons who attended the wake and were in close contact with Patient 9 became ill between 14 and 40 days after the wake for Patient 2.”
Quote in the paperSubstantial claim - Findingown data§ Epidemiologic Analysis
Approximately 82 health care workers were exposed to symptomatic patients with confirmed ANDV infection at Hospital Esquel Zonal from December 2 to December 13, 2018.
“Approximately 82 health care workers were exposed to symptomatic patients with confirmed ANDV infection at Hospital Esquel Zonal from December 2 to December 13, 2018.”
Quote in the paperSubstantial claim - Findingown data§ Epidemiologic Analysis
The posterior median R value across the entire outbreak was 1.19 (95% credible interval, 0.82 to 1.56).
“The posterior median R value across the entire outbreak was 1.19 (95% credible interval, 0.82 to 1.56)”
Quote in the paperSubstantial claim - Findingnone given§ Epidemiologic Analysis
The remaining 12 patients were each in contact with at least one previously symptomatic patient.
“The remaining 12 patients were each in contact with at least one previously symptomatic patient.”
Quote in the paperSubstantial claim - Findingcitation§ Epidemiologic Analysis
Around December 31, 2018, after the 18th case of ANDV hantavirus pulmonary syndrome was confirmed, public health authorities ordered isolation measures for symptomatic patients and self-quarantine for high-risk case contacts.
“Around December 31, 2018, after the 18th case of ANDV hantavirus pulmonary syndrome was confirmed, public health authorities ordered isolation measures for symptomatic patients and self-quarantine for high-risk case contacts (Supplementary Appendix 1).”
Quote in the paperSubstantial claim - Findingown data§ Phylogenetic, Genomic, and Immunologic Analyses
The phylogenetic analysis confirmed that the outbreak was caused by a single spillover event.
“The phylogenetic analysis confirmed that the outbreak was caused by a single spillover event (Fig. 1A).”
Quote in the paperSubstantial claim - Findingown data§ Phylogenetic, Genomic, and Immunologic Analyses
Sequences shared 99.8 to 100.0% identity with the other ANDV sequences involved in the outbreak.
“Sequences shared 99.8 to 100.0% identity with the other ANDV sequences involved in the outbreak (Table S5).”
Quote in the paperNot a substantial claim - Findingown data§ Laboratory Studies
Hematologic abnormalities, including thrombocytopenia, lymphopenia, leukocytosis, and neutrophilia, were observed in the majority of cases.
“Hematologic abnormalities, including thrombocytopenia, lymphopenia, leukocytosis, and neutrophilia, were also observed in the majority of cases.”
Quote in the paperNot a substantial claim - Findingown data§ Epidemiologic Analysis
Of the 45 persons who worked in the intensive care unit and emergency department, only a small number used any form of personal protective equipment while they were in direct contact with an infected patient.
“Of the 45 persons who worked in the intensive care unit and emergency department, only a small number used any form of personal protective equipment (including N95 respirators [N100 respirators for intubations and cleaning], goggles, and disposable laboratory coats) while they were in direct contact with an infected patient.”
Quote in the paperSubstantial claim - Findingown data§ Epidemiologic Analysis
The mean (±SD) serial interval (the time from symptom onset in a primary case to symptom onset in an epidemiologically linked secondary case) was approximately 23±7 days.
“The mean (±SD) serial interval (the time from symptom onset in a primary case to symptom onset in an epidemiologically linked secondary case) was approximately 23±7 days (Fig. S4).”
Quote in the paperNot a substantial claim - Findingnone given§ Epidemiologic Analysis
Four patients (Patients 10, 29, 33, and 34) may have been infected by more than one person.
“Four patients (Patients 10, 29, 33, and 34) may have been infected by more than one person.”
Quote in the paperNot a substantial claim - Findingown data§ Clinical Characteristics
Fatal cases were characterized by severe compromise in hemodynamic function, as evidenced by marked hypotension.
“Fatal cases were characterized by severe compromise in hemodynamic function, as evidenced by marked hypotension.”
Quote in the paperNot a substantial claim - Findingown data§ Epidemiologic Analysis
The first person-to-person transmission event was traced to a birthday party with approximately 100 guests.
“Our findings traced the first person-to-person transmission event to a birthday party with approximately 100 guests.”
Quote in the paperSubstantial claim - Findingown data§ Serologic Analysis
Patients with a less pronounced elevation of stem cell growth factor β were more likely to be spreaders than nonspreaders (odds ratio, 0.27; 95% CI, 0.09 to 0.73).
“Patients with higher levels of interleukin-1β (odds ratio, 2.4; 95% CI, 1.3 to 5.5) or a less pronounced elevation of stem cell growth factor β (odds ratio, 0.27; 95% CI, 0.09 to 0.73) were more likely to be spreaders than nonspreaders.”
Quote in the paperSubstantial claim - Findingown data§ Discussion
The median R value for the entire 15-week period was 1.19.
“The median R value for the entire 15-week period was 1.19.”
Quote in the paperNot a substantial claim - Findingown data§ Serologic Analysis
Stem cell growth factor β and the Z value in patients with the Epuyén/18-19 strain of ANDV were negatively correlated (r = -0.41; 95% CI, -0.61 to -0.15).
“Notably, stem cell growth factor β and the Z value in patients with the Epuyén/18-19 strain of ANDV were negatively correlated (r = -0.41;95% CI, -0.61 to -0.15).”
Quote in the paperNot a substantial claim - Findingown data§ Phylogenetic, Genomic, and Immunologic Analyses
Next-generation sequencing yielded complete or nearly complete ANDV genomic sequences (from the S, M, and L segments), with more than 98% coverage, from 27 of 28 available specimens.
“Next-generation sequencing yielded complete or nearly complete ANDV genomic sequences (from the S, M, and L segments), with more than 98% coverage, from 27 of 28 available specimens (Table S3).”
Quote in the paperSubstantial claim - Findingown data§ Epidemiologic Analysis
The transmission and exposure events for all 33 secondary cases and four waves of human infection were reconstructed on the basis of the known and probable epidemiologic relationships among cases.
“The transmission and exposure events for all 33 secondary cases and four waves of human infection were reconstructed on the basis of the known and probable epidemiologic relationships among cases (Fig. 1B).”
Quote in the paperSubstantial claim- Rests on an assumption: The known and probable epidemiologic relationships among cases are accurate enough to reconstruct person-to-person transmission events.
- Findingown data§ Laboratory Studies
Among the first 18 patients with confirmed infection (who had not yet been isolated), those with higher viral loads were more likely to spread infection to another person (odds ratio for elevated viral load, 1.7; 95% CI, 1.2 to 3.6).
“Among the first 18 patients with confirmed infection (who had not yet been isolated), those with higher viral loads were more likely to spread infection to another person (odds ratio for elevated viral load, 1.7; 95% CI, 1.2 to 3.6).”
Quote in the paperSubstantial claim - Findingown data§ Laboratory Studies
Z values were positively correlated with LDH levels in patients before they were isolated (r = 0.54; 95% CI, 0.09 to 0.80).
“positive correlations were found between Z values and LDH (r = 0.54; 95% CI, 0.09 to 0.80), AST (r = 0.56; 95% CI, 0.10 to 0.82), and ALT levels (r = 0.63; 95% CI, 0.21 to 0.85) in patients before they were isolated.”
Quote in the paperNot a substantial claim - Findingown data§ Discussion
The Z value was correlated with decreasing prothrombin index.
“The Z value was correlated with increasing ALT levels in the blood, longer prothrombin response times, and decreasing prothrombin index.”
Quote in the paperSubstantial claim - Findingown data§ Laboratory Studies
Z values were positively correlated with AST levels in patients before they were isolated (r = 0.56; 95% CI, 0.10 to 0.82).
“positive correlations were found between Z values and LDH (r = 0.54; 95% CI, 0.09 to 0.80), AST (r = 0.56; 95% CI, 0.10 to 0.82), and ALT levels (r = 0.63; 95% CI, 0.21 to 0.85) in patients before they were isolated.”
Quote in the paperNot a substantial claim - Findingown data§ Serologic Analysis
Patients with higher levels of interleukin-1β were more likely to be spreaders than nonspreaders (odds ratio, 2.4; 95% CI, 1.3 to 5.5).
“Patients with higher levels of interleukin-1β (odds ratio, 2.4; 95% CI, 1.3 to 5.5) or a less pronounced elevation of stem cell growth factor β (odds ratio, 0.27; 95% CI, 0.09 to 0.73) were more likely to be spreaders than nonspreaders.”
Quote in the paperSubstantial claim - Findingown data§ Discussion
The R value after control measures were implemented was 0.96.
“The blue dashed line indicates the median R value before control measures were implemented (R = 2.12) by the Ministry of Health, and the red dashed line indicates the R value after control measures were implemented (R = 0.96); these values are shown for each 1-week period, where possible.”
Quote in the paperSubstantial claim - Findingown data§ Clinical Characteristics
During the prodromal phase, patients with secondary cases of infection with the Epuyén/18-19 strain of ANDV presented with the typical clinical symptoms associated with ANDV hantavirus pulmonary syndrome.
“During the prodromal phase, patients with secondary cases of infection with the Epuyén/18-19 strain of ANDV presented with the typical clinical symptoms associated with ANDV hantavirus pulmonary syndrome (Table 2).”
Quote in the paperNot a substantial claim - Findingown data§ Phylogenetic, Genomic, and Immunologic Analyses
A median-joining haplotype network showed that the infections in 78% of patients (21 of 27 patients) shared a single viral haplotype that formed a central node from which six additional haplotypes spread out.
“A medianjoining haplotype network showed that the infections in 78% of patients (21 of 27 patients) shared a single viral haplotype that formed a central node from which six additional haplotypes spread out (Fig. 1C).”
Quote in the paperSubstantial claim - Findingown data§ Discussion
Few genomic mutations were identified among the strains involved in the outbreak transmitted person-to-person, despite Epuyén/18-19 and Epilink/96 being sampled 22 years apart.
“Although the Epuyén/18-19 and Epilink/96 sequences were sampled 22 years apart, few genomic mutations were identified among the strains involved in the outbreak that were transmitted from person to person.”
Quote in the paperSubstantial claim - Findingown data§ Epidemiologic Analysis
Two additional nosocomial transmission events occurred at the smaller Epuyén Rural Hospital, for which information on the use of standard personal protective equipment was not available.
“Two additional nosocomial transmission events occurred at the smaller Epuyén Rural Hospital, for which information on the use of standard personal protective equipment was not available.”
Quote in the paperNot a substantial claim - Findingown data§ Phylogenetic, Genomic, and Immunologic Analyses
The Epuyén/18-19 sequences are most closely related to those recovered from an unrelated case of ANDV hantavirus pulmonary syndrome that occurred in 2018 (the NRC-6/18 strain) in a patient from a neighboring town and to the Epilink/96 strain.
“The Epuyén/18-19 sequences are most closely related to those recovered from an unrelated case of ANDV hantavirus pulmonary syndrome that occurred in 2018 (the NRC-6/18 strain) in a patient from a neighboring town and to the Epilink/96 strain.”
Quote in the paperNot a substantial claim - Findingown data§ Serologic Analysis
Bivariate analyses revealed differences in the levels of interleukin-1β, interleukin-18, interleukin-13, stem cell factor, and stem cell growth factor β between all spreaders and nonspreaders.
“Bivariate analyses revealed differences in the levels of interleukin-1β, interleukin-18, interleukin-13, stem cell factor, and stem cell growth factor β between all spreaders and nonspreaders (Table 3).”
Quote in the paperSubstantial claim - Findingnone given§ Clinical Characteristics
Except for Patient 5, all person-to-person spreaders of ANDV presented with compromised respiratory function.
“Except for Patient 5, all person-to-person spreaders of ANDV presented with compromised respiratory function.”
Quote in the paperNot a substantial claim - Findingown data§ Phylogenetic, Genomic, and Immunologic Analyses
Phylogenetic analysis confirmed that the Epuyén/18-19 strain belongs to the ANDV variant.
“Phylogenetic analysis confirmed that the Epuyén/18-19 strain belongs to the ANDV variant (Fig. 1A, Fig. S1, and Table S4).”
Quote in the paperNot a substantial claim - Findingown data§ Discussion
The Z value was correlated with longer prothrombin response times.
“The Z value was correlated with increasing ALT levels in the blood, longer prothrombin response times, and decreasing prothrombin index.”
Quote in the paperNot a substantial claim - Findingown data§ Clinical Characteristics
The most common clinical feature after the prodromal phase was the rapid onset of acute respiratory distress, marking the onset of the cardiopulmonary phase, which was evidenced by different degrees of compromise of respiratory function in 25 of 33 patients (76%).
“The most common clinical feature after the prodromal phase was the rapid onset of acute respiratory distress, marking the onset of the cardiopulmonary phase, which was evidenced by different degrees of compromise of respiratory function (in 25 of 33 patients [76%]).”
Quote in the paperNot a substantial claim - Findingown data§ Laboratory Studies
The viral load in patients before isolation was positively correlated with patient age (r = 0.46; 95% CI, 0.14 to 0.70).
“The viral load in patients before isolation was also positively correlated with patient age (r = 0.46; 95% CI, 0.14 to 0.70).”
Quote in the paperNot a substantial claim - Findingown data§ Phylogenetic, Genomic, and Immunologic Analyses
Except for the haplotype of the specimen obtained from Patient 22, all the variant haplotypes were in terminal nodes (i.e., they were not transmitted to secondary cases).
“Except for the haplotype of the specimen obtained from Patient 22, all the variant haplotypes were in terminal nodes (i.e., they were not transmitted to secondary cases).”
Quote in the paperNot a substantial claim - Findingown data§ Laboratory Studies
Z values were positively correlated with ALT levels in patients before they were isolated (r = 0.63; 95% CI, 0.21 to 0.85).
“positive correlations were found between Z values and LDH (r = 0.54; 95% CI, 0.09 to 0.80), AST (r = 0.56; 95% CI, 0.10 to 0.82), and ALT levels (r = 0.63; 95% CI, 0.21 to 0.85) in patients before they were isolated.”
Quote in the paperNot a substantial claim - Findingown data§ Epidemiologic Analysis
Five persons (Patients 2 through 6) who had been seated close to Patient 1 reported onset of symptoms consistent with ANDV hantavirus pulmonary syndrome between 17 and 24 days after the party.
“Five persons (Patients 2 through 6) who had been seated close to Patient 1 reported onset of symptoms consistent with ANDV hantavirus pulmonary syndrome between 17 and 24 days after the party (Fig. S3).”
Quote in the paperSubstantial claim - Findingown data§ Epidemiologic Analysis
One secondary nosocomial transmission event occurred at Hospital Esquel Zonal.
“Nonetheless, we identified one secondary nosocomial transmission event that occurred at Hospital Esquel Zonal, which is an advanced health care facility.”
Quote in the paperSubstantial claim - Interpretationown data§ Abstract
Among patients with ANDV hantavirus pulmonary syndrome, high viral titers in combination with attendance at massive social gatherings or extensive contact among persons were associated with a higher likelihood of transmission.
“Among patients with ANDV hantavirus pulmonary syndrome, high viral titers in combination with attendance at massive social gatherings or extensive contact among persons were associated with a higher likelihood of transmission.”
Quote in the paperSubstantial claim - Interpretationown data§ Abstract
After a single introduction of ANDV from a rodent reservoir into the human population, transmission was driven by 3 symptomatic persons who attended crowded social events.
“After a single introduction of ANDV from a rodent reservoir into the human population, transmission was driven by 3 symptomatic persons who attended crowded social events.”
Quote in the paperSubstantial claim - Interpretationreasoning§ Epidemiologic Analysis
Patient 2 was the most likely source for six infections in other persons during the early prodromal phase because of his active social life.
“Patient 2 was the most likely source for six infections in other persons during the early prodromal phase because of his active social life.”
Quote in the paperSubstantial claim - Interpretationreasoning§ Discussion
Genetic factors facilitating person-to-person transmission may have been maintained in reservoir rodent host populations before the October 2018 cross-species transmission.
“Genetic factors that facilitated person-to-person transmission may have been maintained in reservoir rodent host populations before the cross-species transmission that occurred in October 2018.”
Quote in the paperSubstantial claim - Study design and conductreasoning§ Discussion
The measures limited our ability to rule out alternative avenues of transmission in multipatient homes.
“However, this also limited our ability to rule out alternative avenues of transmission in multipatient homes.”
Quote in the paperNot a substantial claim - Interpretationown data§ Discussion
The absence of evidence for ANDV adaptation within or between hosts or for differences in viral diversity between spreaders and nonspreaders indicates that permissive ecology and social factors have a more substantial influence than genetic changes in sustaining person-to-person transmission in human hosts.
“The absence of evidence for ANDV adaptation within or between hosts or for differences in viral diversity between spreaders and nonspreaders indicates that permissive ecology and social factors have a more substantial influence than genetic changes in sustaining person-to-person transmission in human hosts.”
Quote in the paperSubstantial claim - Interpretationown data§ Discussion
Based on epidemiologic and genomic investigations, inhalation of droplets or aerosolized virions may have been the route of infection.
“On the basis of both the epidemiologic and genomic investigations of person-to-person transmission events, it appears that inhalation of droplets or aerosolized virions may have been the routes of infection.”
Quote in the paperSubstantial claim - Interpretationown data§ Discussion
Our data suggest that three events of nosocomial transmission, not involving health care personnel, occurred inside hospital facilities during the Epuyén outbreak in 2018 and 2019.
“However, our data suggest that three events of nosocomial transmission, although not involving health care personnel, occurred inside hospital facilities during the outbreak in Epuyén in 2018 and 2019.”
Quote in the paperSubstantial claim - Interpretationown data§ Discussion
The substantial up-regulation of IL-18, IL-1β, IL-13, SCF, and SCGF-β shows a broad but dysregulated immune response.
“Several differences between the patterns of immune response in all spreaders and nonspreaders were also notable, but the substantial up-regulation of the cytokines interleukin-18 (proinflammatory), interleukin-1β (inflammatory response), interleukin-13 (Th2), stem cell factor (hematopoiesis), and stem cell growth factor β (hematopoiesis) show a broad but dysregulated immune response.”
Quote in the paperSubstantial claim - Premisecitation§ Epidemiologic Analysis
The spread of the Epilink/96 strain of ANDV was estimated to have had a mean R value of 0.7 (90% confidence interval [CI], 0.2 to 1.1).
“In comparison, the spread of the Epilink/96 strain of ANDV was estimated to have had a mean R value of 0.7 (90% confidence interval [CI], 0.2 to 1.1).23”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [23] 23. Stein RA. Super-spreaders in infec- tious diseases. Int J Infect Dis 2011; 15(8): e510-e513.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationown data§ Discussion
The 2018-2019 Epuyén outbreak of ANDV hantavirus pulmonary syndrome shows evidence of person-to-person transmission of an orthohantavirus.
“The outbreak of ANDV hantavirus pulmonary syndrome in Epuyén in 2018 and 2019 shows evidence of person-to-person transmission of an orthohantavirus.”
Quote in the paperSubstantial claim - Interpretationown data§ Epidemiologic Analysis
On the basis of evidence from five reconstructed person-to-person transmission events, the route of infection in secondary cases was possibly through inhalation of droplets or aerosolized virions.
“On the basis of evidence from five reconstructed person-to-person transmission events, the route of infection in secondary cases was possibly through inhalation of droplets or aerosolized virions (Table 1 and Table S7).”
Quote in the paperSubstantial claim- Rests on an assumption: The known and probable epidemiologic relationships among cases are accurate enough to reconstruct person-to-person transmission events.
- May combine two claims. 28
- Classified as probably not a substantial claim. 10
May combine two claims.
Premisecitation§ HSuper-spreading events and sustained person-to-person transmission have not been reported previously in outbreaks of hantavirus pulmonary syndrome but have been observed in disease outbreaks caused by Ebola virus, Middle East respiratory syndrome coronavirus, severe acute respiratory syndrome coronavirus (SARS-CoV), and SARS-CoV-2.
“Super-spreading events and sustained person-to-person transmission have not been reported previously in outbreaks of hantavirus pulmonary syndrome but have been observed in disease outbreaks caused by Ebola virus, 25 Middle East respiratory syndrome coronavirus, severe acute respiratory syndrome coronavirus (SARS-CoV), and SARS-CoV-2.26,27”
Quote in the paperSubstantial claim1 of 3 sources checked- cites [25] 25. Holmes KV. Structural biology: adap- tation of SARS coronavirus to humans. Science 2005; 309: 1822-3.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [26] 26. Liu Y, Eggo RM, Kucharski AJ. Sec- ondary attack rate and superspreading events for SARS-CoV-2. Lancet 2020; 395: e47. source
Split into 2 atoms — 0 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 1 unverifiable. Expand the claim to see per-atom verdicts.
Experimental — accuracy not yet measured - cites [27] 27. Hantavirus -Americas (02): Chile (Los Lagos) ex Argentina (Chubut). Inter- national Society for Infectious Diseases, January 7, 2009 (http://www . promedmail . org/ post/ 20190108 . 6248358.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
Premisecitation§ DiscussionPrevious ANDV hantavirus pulmonary syndrome outbreaks in 1996 and 2011 included person-to-person nosocomial transmission involving health care workers, whereas outbreaks in 1999 and 2002 did not.
“Previous ANDV hantavirus pulmonary syndrome outbreaks in 1996 6 and 2011 37 included person-to-person nosocomial transmission involving health care workers, whereas outbreaks in 1999 38 and 2002 17 did not.”
Quote in the paperNot a substantial claim1 of 3 sources checked- cites [6] 6. Martinez VP, Bellomo CM, Cacace ML, Suárez P, Bogni L, Padula PJ. Hanta- virus pulmonary syndrome in Argentina, 1995-2008. Emerg Infect Dis 2010; 16: 1853- 60. source
Citation 17 is attached to the assertion that a 2002 outbreak did not involve person-to-person nosocomial transmission among health care workers. The Results table and Discussion describe clustered cases and person-to-person transmission during 1995–2008, but do not identify the claimed 2002 outbreak or address nosocomial transmission in it. Searches for 2002, nosocomial transmission, and health care workers found no passage that settles the assertion. (LLM, conf=0.74)
Experimental — accuracy not yet measured - cites [37] 37. Castillo C, Villagra E, Sanhueza L, Ferres M, Mardones J, Mertz GJ. Preva- lence of antibodies to hantavirus among family and health care worker contacts of persons with hantavirus cardiopulmo- nary syndrome: lack of evidence for noso- comial transmission of Andes virus to health care workers in Chile. Am J Trop Med Hyg 2004; 70: 302-4. source
- cites [38] 38. Parrish CR, Holmes EC, Morens DM, et al. Cross-species virus transmission and the emergence of new epidemic dis- eases. Microbiol Mol Biol Rev 2008; 72: 457-70. source
May combine two claims.
Interpretationcitation§ DiscussionThe measures reduced the number of potential case contacts, which may have allowed high-risk household contacts to be attended and treated and may have resulted in earlier detection of infection.
“In addition, these measures reduced the number of potential case contacts, which may have allowed high-risk household contacts to be attended to and treated and may have resulted in detection of infection in the earlier stages of progression of hantavirus pulmonary syndrome.18”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [18] 18. Lázaro ME, Cantoni GE, Calanni LM, et al. Clusters of hantavirus infection, southern Argentina. Emerg Infect Dis 2007; 13: 104-10. source
The Results (Type B Clusters; page unavailable) say contact surveillance identified two acute infections in children, supporting the detection component. The Discussion recommends precautions, but does not say the measures reduced the number of potential contacts or enabled household contacts to be attended to and treated, nor does it link the measures to earlier detection. (LLM, conf=0.82)
Experimental — accuracy not yet measured
May combine two claims.
Findingown data§ AbstractThe median reproductive number was 2.12 before the control measures were enforced and decreased to 0.96 after the measures were implemented.
“The median reproductive number (the number of secondary cases caused by an infected person during the infectious period) was 2.12 before the control measures were enforced and decreased to 0.96 after the measures were implemented.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown data§ AbstractFrom November 2018 through February 2019, person-to-person transmission of Andes virus (ANDV) hantavirus pulmonary syndrome occurred in Chubut Province, Argentina, and resulted in 34 confirmed infections and 11 deaths.
“From November 2018 through February 2019, person-to-person transmission of Andes virus (ANDV) hantavirus pulmonary syndrome occurred in Chubut Province, Argentina, and resulted in 34 confirmed infections and 11 deaths.”
Quote in the paperSubstantial claimMay combine two claims.
Findingcitation§ Phylogenetic, Genomic, and Immunologic AnalysesThe Epilink/96 strain of ANDV was isolated from one specimen; this was the strain responsible for the 1996 outbreak in El Bolsón.
“The Epilink/96 strain of ANDV was isolated from one specimen; this was the strain responsible for the 1996 outbreak in El Bolsón, approximately 40 km north of Epuyén.10”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [10] 10. Enría D, Padula P, Segura EL, et al. Hantavirus pulmonary syndrome in Ar- gentina: possibility of person to person transmission. Medicina (B Aires) 1996; 56: 709-11. source
May combine two claims.
Findingown data§ AbstractFull genome sequencing of the ANDV strain involved in this outbreak was performed with specimens from 27 patients and showed that the strain that was present (Epuyén/18-19) was similar to the causative strain (Epilink/96) in the first known person-to-person transmission of hantavirus pulmonary syndrome caused by ANDV, which occurred in El Bolsón, Argentina, in 1996.
“sequencing of the ANDV strain involved in this outbreak was performed with specimens from 27 patients and showed that the strain that was present (Epuyén/18-19) was similar to the causative strain (Epilink/96) in the first known person-to-person transmission of hantavirus pulmonary syndrome caused by ANDV, which occurred in El Bolsón, Argentina, in 1996.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown data§ AbstractDisease severity, genomic diversity, age, and time spent in the hospital had no clear association with secondary transmission.
“Disease severity, genomic diversity, age, and time spent in the hospital had no clear association with secondary transmission.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown data§ Epidemiologic AnalysisThe median weekly R value was 6.56 (95% credible interval, 2.55 to 13.51), peaked from week 47 through week 48 (November 25 to December 1, 2018), and decreased to below 1.00 in late January 2019.
“The median weekly R value (6.56; 95% credible interval, 2.55 to 13.51) peaked from week 47 through week 48 (November 25 to December 1, 2018) and decreased to below 1.00 in late January 2019 (Fig. 1D).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown data§ Epidemiologic AnalysisThree patients were the main drivers of the outbreak of ANDV hantavirus pulmonary syndrome in Epuyén and were the source of 64% of secondary cases (21 of 33 cases).
“Three patients were the main drivers of the outbreak of ANDV hantavirus pulmonary syndrome in Epuyén and were the source of 64% of secondary cases (21 of 33 cases).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown data§ Laboratory StudiesPatients with higher ALT levels and more severe thrombocytopenia were also more likely to be super-spreaders (odds ratio for high ALT level, 1.6; 95% CI, 1.1 to 2.7; odds ratio for low platelet count, 2.9; 95% CI, 1.2 to 13.2).
“Patients with higher ALT levels and more severe thrombocytopenia were also more likely to be super-spreaders (odds ratio for high ALT level, 1.6; 95% CI, 1.1 to 2.7; odds ratio for low platelet count, 2.9; 95% CI, 1.2 to 13.2).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingcitation§ DiscussionThe median R value before control measures were implemented was 2.12.
“The blue dashed line indicates the median R value before control measures were implemented (R = 2.12) by the Ministry of Health, and the red dashed line indicates the R value after control measures were implemented (R = 0.96); these values are shown for each 1-week period, where possible.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown data§ Epidemiologic AnalysisPatient 2 died 16 days after symptom onset, and his spouse (Patient 9) was febrile while attending his wake.
“Patient 2 died 16 days after symptom onset, and his spouse (Patient 9) was febrile while attending his wake.”
Quote in the paperSubstantial claimMay combine two claims.
Findingnone given§ DiscussionNo association was found between the observed dysregulation and a particular disease outcome, specific immunologic pathway, or potential for secondary transmission.
“We did not find an association between the observed dysregulation and a particular disease outcome, specific immunologic pathway, or potential for secondary transmission.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown data§ Clinical CharacteristicsThe overall case fatality rate was 32% (11 of 34 patients), and the mean time from symptom onset to death was 6.7 days (interquartile range, 4 to 7).
“The overall case fatality rate was 32% (11 of 34 patients), and the mean time from symptom onset to death was 6.7 days (interquartile range, 4 to 7).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingcitation§ Epidemiologic AnalysisThe lower limit of Z for defining a super-spreader patient in the cohort was 4 (99th percentile), which characterizes Patients 1, 2, and 9 as super-spreaders.
“A previously described formula was used to determine that the lower limit of Z for defining a super-spreader patient in our cohort was 4 (99th percentile), which characterizes Patients 1, 2, and 9 as super-spreaders.23,24”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [23] 23. Stein RA. Super-spreaders in infec- tious diseases. Int J Infect Dis 2011; 15(8): e510-e513.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [24] 24. Baize S, Pannetier D, Oestereich L, et al. Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med 2014; 371: 1418-25. source
May combine two claims.
Findingown data§ Laboratory StudiesPatients had elevated lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT), urea, and creatinine levels; prolonged activated partial thromboplastin time; elevated prothrombin index; and prolonged prothrombin time.
“Patients had elevated lactate dehydrogenase (LDH), aspartate aminotransferase (AST), alanine aminotransferase (ALT), urea, and creatinine levels; prolonged activated partial thromboplastin time; elevated prothrombin index (the patient's prothrombin time expressed as a percentage of the normal value); and prolonged prothrombin time (Table 1 and Supplementary Appendix 3).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown data§ Epidemiologic AnalysisThe median R value of secondary person-to-person transmission before the imposed control measures was 2.12 (95% credible interval, 1.24 to 3.35), and the median R value after control measures were implemented decreased to 0.96 (95% credible interval, 0.62 to 1.40).
“The median R value of secondary person-to-person transmission before the imposed control measures was 2.12 (95% credible interval, 1.24 to 3.35), and the median R value after control measures were implemented decreased to 0.96 (95% credible interval, 0.62 to 1.40).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown data§ Epidemiologic AnalysisIn 17 of the 33 (52%) secondary transmission events, transmission from an infected person to a contact who later became infected could be accurately established as the day of onset of fever in the primary case, and the first day of fever was the only time during which there was an interaction between these patients.
“In 17 of the 33 (52%) secondary transmission events, transmission from an infected person to a contact who later became infected could be accurately established as the day of onset of fever in the primary case, and the first day of fever was the only time during which there was an interaction between these patients (Table 1).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown data§ Phylogenetic, Genomic, and Immunologic AnalysesSequences identified in the outbreak shared approximately 94.1 to 100.0% identity with the ANDV RefSeq sequence (GenBank accession number, AF291702-4), with 27 nonsynonymous changes in total.
“Sequences identified in the outbreak shared approximately 94.1 to 100.0% identity with the ANDV RefSeq sequence (GenBank accession number, AF291702-4), with 27 nonsynonymous changes in total (Table S6).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown data§ Laboratory StudiesThe median age of the patients was 38 years (interquartile range, 27 to 58).
“The median age of the patients was 38 years (interquartile range, 27 to 58).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown data§ Clinical CharacteristicsPatients with severe cases had hypotension, progressive pulmonary edema, and hypoxia (often resulting in intubation), whereas patients with mild cases received only supplemental oxygen.
“Patients with severe cases had hypotension, progressive pulmonary edema, and hypoxia (often resulting in intubation), whereas patients with mild cases received only supplemental oxygen.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown data§ Laboratory StudiesZ values were positively correlated with ALT levels (r = 0.51; 95% CI, 0.20 to 0.73) and longer prothrombin response times (r = 0.52; 95% CI, 0.16 to 0.72) and were negatively correlated with the prothrombin index (r = -0.41; 95% CI, -0.69 to -0.02).
“Z values were positively correlated with ALT levels (r = 0.51; 95% CI, 0.20 to 0.73) and longer prothrombin response times (r = 0.52; 95% CI, 0.16 to 0.72) and were negatively correlated with the prothrombin index (r = -0.41;95% CI, -0.69 to -0.02).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown data§ Epidemiologic AnalysisThe index patient (Patient 1) attended the birthday party for 90 minutes and was reportedly symptomatic at the time, with fever and malaise.
“The index patient (Patient 1) attended the event for 90 minutes and was reportedly symptomatic at the time, with fever and malaise.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown data§ Phylogenetic, Genomic, and Immunologic AnalysesNo significant differences in subclonal single-nucleotide polymorphism frequencies or segment diversity were observed between patients in different groups (super-spreaders vs. non-super-spreaders and all spreaders vs. nonspreaders) or between central and terminal haplotypes (P>0.05).
“No significant differences in subclonal single-nucleotide polymorphism frequencies or segment diversity were observed be-tween patients in different groups (super-spreaders vs. non-super-spreaders and all spreaders vs. nonspreaders) or between central and terminal haplotypes (P>0.05) (Fig. S2).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingcitation§ DiscussionLaboratory findings were generally consistent with previous reports.
“Laboratory findings were generally consistent with previous reports.8,[33][34][35][36]”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [8] 8. López N, Padula P, Rossi C, Lázaro ME, Franze-Fernández MT. Genetic iden- tification of a new hantavirus causing severe pulmonary syndrome in Argentina. Virology 1996; 220: 223-6. source
- cites [33] 33. Knust B, Macneil A, Rollin PE. Hanta- virus pulmonary syndrome clinical find- ings: evaluating a surveillance case defi- nition. Vector Borne Zoonotic Dis 2012; 12: 393-9. source
- cites [34] 34. Chapman LE, Ellis BA, Koster FT, et al. Discriminators between hantavirus- infected and -uninfected persons enrolled in a trial of intravenous ribavirin for pre- sumptive hantavirus pulmonary syndrome. Clin Infect Dis 2002; 34: 293-304. source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisecitation§ HSuper-spreading events are frequent in infectious-disease outbreaks and are the result of heterogeneities in the likelihood that a person will infect susceptible hosts and the varying degrees of transmission efficiency of the virus.
“Super-spreading events are frequent in infectious-disease outbreaks and are the result of heterogeneities in the likelihood that a person will infect susceptible hosts and the varying degrees of transmission efficiency of the virus.23,24”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [23] 23. Stein RA. Super-spreaders in infec- tious diseases. Int J Infect Dis 2011; 15(8): e510-e513.
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [24] 24. Baize S, Pannetier D, Oestereich L, et al. Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med 2014; 371: 1418-25. source
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone given§ Data Collection and AnalysesWritten informed consent was obtained from all case patients or their proxy respondents.
“Written informed consent was obtained from all case patients or their proxy respondents.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown data§ Phylogenetic, Genomic, and Immunologic AnalysesSpecimens were obtained from 28 of the 34 patients (82%) with confirmed cases related to the outbreak.
“Specimens were obtained from 28 of the 34 patients (82%) with confirmed cases related to the outbreak (Patients 1 through 20 and Patients 22 through 29)”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone given§ Data Collection and AnalysesAll procedures used in the investigation of the outbreak were approved by the ethics committee of the Instituto Nacional de Genética Médica at the Administración Nacional de Laboratorios e Institutos de Salud Dr. Carlos G. Malbrán (Buenos Aires).
“All procedures used in the investigation of the outbreak were approved by the ethics committee of the Instituto Nacional de Genética Médica at the Administración Nacional de Laboratorios e Institutos de Salud Dr. Carlos G. Malbrán (Buenos Aires).”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown data§ AbstractAfter 18 cases were confirmed, public health officials enforced isolation of persons with confirmed cases and self-quarantine of possible contacts; these measures most likely curtailed further spread.
“After 18 cases were confirmed, public health officials enforced isolation of persons with confirmed cases and self-quarantine of possible contacts; these measures most likely curtailed further spread.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductnone given§ Statistical AnalysisOnly events of person-to-person transmission with a high certainty of infection at the time of the event were included in analyses.
“Only events of person-to-person transmission with a high certainty of infection at the time of the event were included in analyses and are reported as Z values.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisecitation§ HThe incidence of death among persons with hantavirus pulmonary syndrome associated with ANDV is high and has ranged from 21 to 50% in Argentina.
“The incidence of death among persons with hantavirus pulmonary syndrome associated with ANDV is high and has ranged from 21 to 50% in Argentina.[6][7][8]”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [6][7][8]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
Interpretationreasoning§ DiscussionThe estimated difference in R value after enforced self-quarantine and the resulting reduction in cases suggest that these measures limited person-to-person spread of ANDV and may have prevented additional super-spreading events.
“The estimated difference in the R value after the public health authorities in Argentina established enforced self-quarantine of case contacts and the resulting reduction in the number of cases suggest that these measures limited the person-to-person spread of ANDV and therefore may have prevented additional super-spreading events.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Interpretationown data§ 1.8 to 3.1).Differences in laboratory measures may also be attributed to very different clinical findings in the 3 patients who were super-spreaders than in non-superspreaders.
“Differences may also be attributed to very different clinical findings in the 3 patients who were super-spreaders than in non-superspreaders (Supplementary Appendix 1).”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown data§ DiscussionThe correlations suggest that person-to-person spread was related to high viral load and more compromised liver function in the infected patient.
“These correlations suggest that person-to-person spread was related to a high viral load and more compromised liver function in the infected patient.”
Quote in the paperSubstantial claim
The paper relies on this without support.
Factors related to characteristics of the host, the pathogen, and the setting of transmission all contribute to the occurrence of superspreading events in outbreaks.
“Factors related to characteristics of the host, the pathogen, and the setting of transmission all contribute to the occurrence of superspreading events in outbreaks.”
The paper relies on this without support.
The known and probable epidemiologic relationships among cases are accurate enough to reconstruct person-to-person transmission events.
“The transmission and exposure events for all 33 secondary cases and four waves of human infection were reconstructed on the basis of the known and probable epidemiologic relationships among cases (Fig. 1B).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The number of likely cases of human-to-human transmission from the 2018-2019 outbreak in Chubut province of Argentina cannot be determined due to lack of detailed epidemiological and environmental investigation.
“The number of likely cases of human-to-human transmission from the 2018–2019 outbreak in Chubut province of Argentina cannot be determined due to lack of detailed epidemiological and environmental investigation [25].”
From Evidence for Human-to-Human Transmission of Hantavirus: A Systematic Review (2022) · cites this paper as [25]
The Epidemiologic Analysis reports that the authors reconstructed transmission and exposure events for all 33 secondary cases using known and probable epidemiologic relationships. This contradicts the claim that the number of likely person-to-person transmission cases could not be determined for lack of detailed investigation. The Discussion notes uncertainty about alternative transmission routes in multipatient homes, but does not make the claimed assertion. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe authors of the "super-spreaders" article investigated a cluster of 34 cases and claimed that all 33 cases resulting from the index case were caused by human-to-human transmission, but did not consider alternative explanations for the cases.
“The authors of the “super-spreaders” article investigated a cluster of 34 cases and claim that all 33 cases resulting from the index case were caused by human-to-human transmission, but do not consider alternative explanations for the cases.”
From Evidence for Human-to-Human Transmission of Hantavirus: A Systematic Review (2022) · cites this paper as [25]
Split into 2 atoms — 1 confirmed, 0 partially supported, 1 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredHantavirus is not proven to be caused by human-to-human transmission with combined modes of transmission, unlike Ebola, MERS, and SARS.
“this is not the case for hantavirus in the face of the current knowledge and available data.”
From Evidence for Human-to-Human Transmission of Hantavirus: A Systematic Review (2022) · cites this paper as [25]
The Discussion reports evidence of person-to-person Andes virus transmission in the 2018–2019 Epuyén outbreak, including multiple generations of infections and superspreading. The introductory passage says sustained person-to-person transmission and superspreading had not been reported *previously* in hantavirus pulmonary syndrome; it does not say they remained unproven after this outbreak. (LLM, conf=0.89)
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe use of genetic sequencing data to confirm human-to-human transmission has the limitation of only providing strong evidence when cases that occur in different geographic areas have identical sequences.
“While the use of genetic sequencing data to confirm human-to-human transmission has been used in investigations of clusters in Argentina and Chile [7–11, 25, 26, 32, 35], it has the limitation of only providing strong evidence when cases that occur in different geographic areas have identical sequences.”
From Evidence for Human-to-Human Transmission of Hantavirus: A Systematic Review (2022) · cites this paper as [25]
The Discussion (page not available) says the study used genomic information alongside epidemiologic investigation to reconstruct person-to-person transmission in an Argentine outbreak. The Phylogenetic, Genomic, and Immunologic Analyses section reports sequences with 99.8–100.0% identity, but neither section says sequencing provides strong evidence only when cases in different geographic areas have identical sequences. (LLM, conf=0.86)
Experimental — accuracy not yet measuredIn Argentina, all but 1 of the studies showed some evidence of human-to-human transmission in investigations of clusters, with up to 16 likely cases reported between 1996 and 2014.
“In Argentina, all but 1 of the studies showed some evidence of human-to-human transmission in investigations of clusters [8–10, 25, 26, 32], with up to 16 likely cases of human-to-human transmission reported between 1996 and 2014.”
From Evidence for Human-to-Human Transmission of Hantavirus: A Systematic Review (2022) · cites this paper as [25]
The introductory passage (section H; page unavailable) describes a 1996 Argentine outbreak with 16 epidemiologically linked cases and says molecular and epidemiologic evidence suggested person-to-person transmission. It does not establish that all but one cluster study found such evidence, or that 16 cases of human-to-human transmission were likely across 1996–2014. (LLM, conf=0.85)
Experimental — accuracy not yet measured
Of the 14 noncomparative studies, 7 were conducted in Argentina (6 analyses of clusters and 1 seroprevalence study) and 3 in Chile (2 analyses of clusters and 1 seroprevalence study).
“Of the 14 noncomparative studies, 7 were conducted in Argentina (6 analyses of clusters and 1 seroprevalence study) [8–10, 13, 25, 26, 32] and 3 in Chile (2 analyses of clusters and 1 seroprevalence study) [11, 14, 35] (Supplementary Table 2).”
From Evidence for Human-to-Human Transmission of Hantavirus: A Systematic Review (2022) · cites this paper as [25]
Cites
Infectious Diseases of Humans: Dynamics and Control
Anderson, R. M., & May, R. M. (1991) · doi:10.1093/oso/9780198545996.001.0001 · Cited by 6,179 · see citing works
Superspreading and the effect of individual variation on disease emergence
Lloyd-Smith, J. O., Schreiber, S. J., Kopp, P. E., & Getz, W. M. (2005) · Nature · doi:10.1038/nature04153 · Cited by 2,514 · see citing works
A New Framework and Software to Estimate Time-Varying Reproduction Numbers During Epidemics
Cori, A., Ferguson, N. M., Fraser, C., & Cauchemez, S. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kwt133 · Cited by 1,530 · see citing works
Emergence of Zaire Ebola Virus Disease in Guinea
Baize, S., Pannetier, D., Oestereich, L., Rieger, T., Koivogui, L., Magassouba, N., Soropogui, B., Sow, M. S., Keïta, S., De Clerck, H., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1404505 · Cited by 1,366 · see citing works
Genetic Identification of a Hantavirus Associated with an Outbreak of Acute Respiratory Illness
Nichol, S. T., Spiropoulou, C. F., Morzunov, S. P., Rollin, P. E., Ksiazek, T. G., Feldmann, H., Sanchez, A., Childs, J. E., Zaki, S. R., & Peters, C. J. (1993) · Science · doi:10.1126/science.8235615 · Cited by 1,119 · see citing works
Cross-Species Virus Transmission and the Emergence of New Epidemic Diseases
Parrish, C. R., Holmes, E. C., Morens, D. M., Park, E.-C., Burke, D. S., Calisher, C. H., Laughlin, C. A., Saif, L. J., & Daszak, P. (2008) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00004-08 · Cited by 834 · see citing works
Padula, P. J., Edelstein, A., Miguel, S. D. L., López, N. M., Rossi, C. M., & Rabinovich, R. D. (1998) · Virology · doi:10.1006/viro.1997.8976 · Cited by 422 · see citing works
Self-citationTaxonomy of the order Bunyavirales: update 2019
Abudurexiti, A., Adkins, S. T., Alioto, D., et al. (2019) · Archives of Virology · doi:10.1007/s00705-019-04253-6 · Cited by 407 · see citing works
Self-citationSuper-spreaders in infectious diseases
Stein, R. A. (2011) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2010.06.020 · Cited by 388 · see citing works
Secondary attack rate and superspreading events for SARS-CoV-2
Liu, Y., Eggo, R. M., & Kucharski, A. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30462-1 · Cited by 350 · see citing works
The Critical Community Size for Measles in the United States
Bartlett, M. S. (1960) · Journal of the Royal Statistical Society. Series A (General) · doi:10.2307/2343186 · Cited by 326 · see citing works
Person-to-Person Transmission of Andes Virus
Martinez, V. P., Bellomo, C., San Juan, J., Pinna, D., Forlenza, R., Elder, M., & Padula, P. J. (2005) · Emerging Infectious Diseases · doi:10.3201/eid1112.050501 · Cited by 312 · see citing works
Self-citationThe R0 package: a toolbox to estimate reproduction numbers for epidemic outbreaks
Obadia, T., Haneef, R., & Boëlle, P.-Y. (2012) · BMC Medical Informatics and Decision Making · doi:10.1186/1472-6947-12-147 · Cited by 300 · see citing works
Genetic Identification of a New Hantavirus Causing Severe Pulmonary Syndrome in Argentina
LÓPEZ, N., PADULA, P., ROSSI, C., LÁZARO, M. E., & FRANZE-FERNÁNDEZ, M. T. (1996) · Virology · doi:10.1006/viro.1996.0305 · Cited by 288 · see citing works
An Unusual Hantavirus Outbreak in Southern Argentina: Person-to-Person Transmission?
(1997) · Emerging Infectious Diseases · doi:10.3201/eid0302.970210 · Cited by 250 · see citing works
An Outbreak of Hantavirus Pulmonary Syndrome, Chile, 1997
Toro, J., Vega, J. D., Khan, A. S., Mills, J. N., Padula, P., Terry, W., Yadón, Z., Valderrama, R., Ellis, B. A., Pavletic, C., et al. (1998) · Emerging Infectious Diseases · doi:10.3201/eid0404.980425 · Cited by 234 · see citing works
Ferrés, M., Vial, P., Marco, C., Yañez, L., Godoy, P., Castillo, C., Hjelle, B., Delgado, I., Lee, S., Mertz, G. J., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/516786 · Cited by 210 · see citing works
Predicting virus emergence amid evolutionary noise
Geoghegan, J. L., & Holmes, E. C. (2017) · Open Biology · doi:10.1098/rsob.170189 · Cited by 209 · see citing works
Epidemiology of Hantavirus infections in humans: A comprehensive, global overview
Watson, D. C., Sargianou, M., Papa, A., Chra, P., Starakis, I., & Panos, G. (2014) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2013.783555 · Cited by 204 · see citing works
Padula, P., Colavecchia, S. B., Martínez, V. P., et al. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.8.3029-3035.2000 · Cited by 185 · see citing works
Self-citationPerson-to-Person Household and Nosocomial Transmission of Andes Hantavirus, Southern Chile, 2011
Martinez-Valdebenito, C., Calvo, M., Vial, C., Mansilla, R., Marco, C., Palma, R. E., Vial, P. A., Valdivieso, F., Mertz, G., & Ferrés, M. (2014) · Emerging Infectious Diseases · doi:10.3201/eid2010.140353 · Cited by 162 · see citing works
Hantavirus Pulmonary Syndrome in Argentina, 1995–2008
Martinez, V. P., Bellomo, C. M., Cacace, M. L., Suárez, P., Bogni, L., & Padula, P. J. (2010) · Emerging Infectious Diseases · doi:10.3201/eid1612.091170 · Cited by 143 · see citing works
Self-citation(1996) · PubMed · Cited by 125 · see citing works
Self-citationHantavirus Pulmonary Syndrome Due to Andes Virus in Temuco, Chile
Castillo, C., Naranjo, J., Sepúlveda, A., Ossa, G., & Levy, H. (2001) · Chest · doi:10.1378/chest.120.2.548 · Cited by 84 · see citing works
Chapman, L. E., Ellis, B. A., Koster, F. T., Sotir, M., Ksiazek, T. G., Mertz, G. J., Rollin, P. E., Baum, K. F., Pavia, A. T., Christenson, J. C., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/324619 · Cited by 79 · see citing works
Alonso, D. O., Iglesias, A., Coelho, R., Periolo, N., Bruno, A., Córdoba, M. T., Filomarino, N., Quipildor, M., Biondo, E., Fortunato, E., et al. (2019) · Journal of Medical Virology · doi:10.1002/jmv.25446 · Cited by 70 · see citing works
Self-citationClusters of Hantavirus Infection, Southern Argentina
Lázaro, M. E., Cantoni, G. E., Calanni, L. M., Resa, A. J., Herrero, E. R., Iacono, M. A., Enria, D. A., & Cappa, S. M. G. (2007) · Emerging Infectious Diseases · doi:10.3201/eid1301.060404 · Cited by 65 · see citing works
Adaptation of SARS Coronavirus to Humans
Holmes, K. V. (2005) · Science · doi:10.1126/science.1118817 · Cited by 63 · see citing works
Hantavirus Pulmonary Syndrome , Southern Chile, 1995–2012
Riquelme, R., Rioseco, M. L., Bastidas, L., et al. (2015) · Emerging infectious diseases · doi:10.3201/eid2104.141437 · Cited by 56 · see citing works
Multiple scales of selection influence the evolutionary emergence of novel pathogens
Park, M., Loverdo, C., Schreiber, S. J., & Lloyd-Smith, J. O. (2013) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2012.0333 · Cited by 51 · see citing works
Massive plasmablast response elicited in the acute phase of hantavirus pulmonary syndrome
García, M., Iglesias, A., Landoni, V. I., Bellomo, C., Bruno, A., Córdoba, M. T., Balboa, L., Fernández, G. C., Sasiain, M. D. C., Martínez, V. P., et al. (2017) · Immunology · doi:10.1111/imm.12713 · Cited by 50 · see citing works
Self-citationAndes Virus and First Case Report of Bermejo Virus Causing Fatal Pulmonary Syndrome
Padula, P., Valle, M. G. D., García-Alai, M., Cortada, P., Villagra, M., & Gianella, A. (2002) · Emerging infectious diseases · doi:10.3201/eid0804.010300 · Cited by 45 · see citing works
Kuenzli, A. B., Marschall, J., Schefold, J. C., Schafer, M., Engler, O. B., Ackermann-Gäumann, R., Reineke, D. C., Suter-Riniker, F., & Staehelin, C. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy443 · Cited by 34 · see citing works
CASTILLO, C., VILLAGRA, E., SANHUEZA, L., FERRES, M., MARDONES, J., & MERTZ, G. J. (2004) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2004.70.302 · Cited by 32 · see citing works
Novel Strain of Andes Virus Associated with Fatal Human Infection, Central Bolivia
Cruz, C. D., Forshey, B. M., Vallejo, E., et al. (2012) · Emerging infectious diseases · doi:10.3201/eid1805.111111 · Cited by 27 · see citing works
Hantavirus Pulmonary Syndrome Clinical Findings: Evaluating a Surveillance Case Definition
Knust, B., MacNeil, A., & Rollin, P. E. (2012) · Vector-Borne and Zoonotic Diseases · doi:10.1089/vbz.2011.0764 · Cited by 20 · see citing works
Viral load of patients with hantavirus pulmonary syndrome in Argentina
Bellomo, C. M., Pires‐Marczeski, F. C., & Padula, P. J. (2015) · Journal of Medical Virology · doi:10.1002/jmv.24260 · Cited by 19 · see citing works
Self-citationPadula, P. J., Colavecchia, S. B., Martínez, V. P., et al. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.1.417-417.2001
Flagged first, then by citations
Research works printed but not linked: 2
- Kuhn JH Charrel RN. Arthropod-borne and rodent-borne virus infections. In: Jameson JL Fauci AS Kasper DL Hauser SL Longo DL Loscalzo J eds. Harrison’s principles of internal medicine. 20th ed. Columbus OH: McGraw-Hill Education 2018:1489-1509.
- Iglesias AA, Bellomo CM, Martínez VP. Síndrome pulmonar por hantavirus en Buenos Aires, 2009-2014. Medicina (B Aires) 2016;76:1-9.26826986
Cited by
Sorted by citations
Hantavirus in humans: a review of clinical aspects and management
Vial, P., Marcela Ferrés, G., Vial, C., Klingström, J., Ahlm, C., López, R., Corre, N. L., & MERTZ, G. J. (2023) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(23)00128-7 · Cited by 265 · see citing works
Hulswit, R. J. G., Paesen, G. C., Bowden, T. A., et al. (2021) · Viruses · doi:10.3390/v13020353 · Cited by 86 · see citing works
“tions have been reported, including LASV, CCHFV (reviewed in [17]) and ANDV [18,19].”
BackgroundEvidence for Human-to-Human Transmission of Hantavirus: A Systematic Review
Toledo, J., Haby, M. M., Reveiz, L., Sosa Leon, L., Angerami, R., & Aldighieri, S. (2022) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab461 · Cited by 78 · see citing works
“Furthermore, despite the known limitations of investigations of cases (without any suitable control group), some authors have made some rather alarming claims, such as the existence of “super-spreaders,” a term that is currently in vogue due to the coronavirus disease 2019 pandemic but was also used for outbreaks caus…”
BackgroundInfluentialKoehler, F. C., Cristanziano, V. D., Späth, M. R., Hoyer-Allo, K. J. R., Wanken, M., Müller, R., & Burst, V. R. (2022) · Clinical Kidney Journal · doi:10.1093/ckj/sfac008 · Cited by 70 · see citing works
A Brief History of Bunyaviral Family Hantaviridae
Kuhn, J. H., & Schmaljohn, C. S. (2023) · Diseases · doi:10.3390/diseases11010038 · Cited by 59 · see citing works
Self-citationViral shedding and viraemia of Andes virus during acute hantavirus infection: a prospective study
Marcela Ferrés, G., Martínez-Valdebenito, C., Henriquez, C., Marco, C., Angulo, J., Barrera, A., Palma, C., Pinto, G. B., Cuiza, A., Ferreira, L., et al. (2024) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(24)00142-7 · Cited by 62 · see citing works
Zoonotic Hantaviridae with Global Public Health Significance
Chen, R.-X., Gong, H., Xiu, W., et al. (2023) · Viruses · doi:10.3390/v15081705 · Cited by 49 · see citing works
“It usually occurs after close c ntact with an infected person [76].”
BackgroundWilliams, E. P., Spruill-Harrell, B., Taylor, M. K., Lee, J., Nywening, A. V., Yang, Z., Nichols, J. H., Camp, J. V., Owen, R. D., & Jonsson, C. B. (2021) · Viruses · doi:10.3390/v13081509 · Cited by 52 · see citing works
Engdahl, T. B., Kuzmina, N. A., Ronk, A. J., Mire, C. E., Hyde, M. A., Kose, N., Josleyn, M. D., Sutton, R. E., Mehta, A., Wolters, R. M., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109086 · Cited by 48 · see citing works
“…are transmitted mainly through the inhalation of aerosolized rodent excreta; however, recent outbreaks of ANDV infection have also included human-to-human transmission through prolonged, direct contact with infected individuals (Alonso et al., 2020; Martinez et al., 2005; Martínez et al., 2020).”
Hantavirus Replication Cycle—An Updated Structural Virology Perspective
Meier, K., Thorkelsson, S. R., Quemin, E. R. J., & Rosenthal, M. (2021) · Viruses · doi:10.3390/v13081561 · Cited by 49 · see citing works
“Humans are generally considered as dead-end hosts with the exception of some reports of person-to-person transmission for ANDV in Argentina [5], including recent cases of “super-spreaders” of the same viral strain [6] and the suspicion of transmission via the transfusion of platelets and blood products for PUUV in Fin…”
BackgroundMittler, E., Wec, A. Z., Tynell, J., Guardado‐Calvo, P., Byström, J. W., Polanco, L. C., O’Brien, C. M., Slough, M. M., Abelson, D. M., Serris, A., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abl5399 · Cited by 46 · see citing works
“An SNV outbreak among overnight visitors in California’s Yosemite National Park in 2012 (8) and a singular ANDV superspreader outbreak in Argentina in 2018–2019 (2, 9) highlight the public health risks posed by hantaviruses.”
BackgroundAntiviral Efficacy of Ribavirin and Favipiravir against Hantaan Virus
Mayor, J., Engler, O. B., & Rothenberger, S. (2021) · Microorganisms · doi:10.3390/microorganisms9061306 · Cited by 44 · see citing works
Engdahl, T. B., Binshtein, E., Brocato, R. L., Kuzmina, N. A., Principe, L. M., Kwilas, S. A., Kim, R. K., Chapman, N. S., Porter, M. S., Guardado‐Calvo, P., et al. (2023) · eLife · doi:10.7554/elife.81743 · Cited by 43 · see citing works
Tortosa, F. G., Perré, F., Tognetti, C., Lossetti, L., Carrasco, G., Guaresti, G., Iglesias, A., Espasandin, Y., & Izcovich, A. (2024) · BMC Public Health · doi:10.1186/s12889-024-20014-w · Cited by 43 · see citing works
“For example, studies conducted in Chile and Argentina have documented probable cases of human-to-human transmission of ANDV, especially in close household contacts, such as sexual partners [146, 147].”
BackgroundSelf-citationStructural and mechanistic basis of neutralization by a pan-hantavirus protective antibody
Mittler, E., Serris, A., Esterman, E. S., Florez, C., Polanco, L. C., O’Brien, C. M., Slough, M. M., Tynell, J., Gröning, R., Sun, Y., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adg1855 · Cited by 37 · see citing works
“The capacity of ANDV to spread through human-to-human contact (4, 5) and the essentially unknown but growing potential for hantavirus emergence suggest that the public health risks posed by these agents have been underestimated (6).”
BackgroundGenetic depletion studies inform receptor usage by virulent hantaviruses in human endothelial cells
Dieterle, M. E., Solà-Riera, C., Ye, C., et al. (2021) · eLife · doi:10.7554/elife.69708 · Cited by 30 · see citing works
Oral and ocular transmission of severe fever with thrombocytopenia syndrome virus
Zhou, C., Qi, R., Qin, X., Fang, L.-Z., Han, H., Lei, X.-Y., & Yu, X.-J. (2022) · Infectious Medicine · doi:10.1016/j.imj.2021.12.002 · Cited by 23 · see citing works
Therapeutic Efficacy of Human Monoclonal Antibodies against Andes Virus Infection in Syrian Hamsters
Williamson, B. N., Prescott, J. B., Garrido, J. L. V., et al. (2021) · Emerging infectious diseases · doi:10.3201/eid2710.210735 · Cited by 22 · see citing works
“The large 2018 ANDV outbreak in the Austral Patagonian region at Epuyén village (Chubut Province, Argentina) reemphasized the probability of person-to-person transmission, highlighting the urgent need for specifi c therapies and vaccines (5).”
BackgroundMechanistic basis for potent neutralization of Sin Nombre hantavirus by a human monoclonal antibody
Stass, R., Engdahl, T. B., Chapman, N. S., Wolters, R. M., Handal, L. S., Diaz, S. M., Crowe, J. E., & Bowden, T. A. (2023) · Nature Microbiology · doi:10.1038/s41564-023-01413-y · Cited by 22 · see citing works
Pathogenicity and virulence of Rodent-Borne Orthohantaviruses
(2025) · doi:10.1080/21505594.2025.2553784 · Cited by 21 · see citing works
“However, person-to-person transmission has been limited geographically to Chile and Argentina [12,13,179].”
Velavan, T. P., & Schmidt‐Chanasit, J. (2026) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2026.108778 · Cited by 26 · see citing works
Kuzmin, I. V., Soto-Acosta, R., Pruitt, L., Wasdin, P. T., Kedarinath, K., Hernandez, K. R., Gonzales, K. A., Hill, K., Weidner, N. G., Mire, C. E., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50774-3 · Cited by 26 · see citing works
“ANDV caused a human outbreak with aggressive airborne human-to-human transmission and multiple fatalities in 2019 – 2020 49 , highlighting its epidemic potential.”
Disparate macrophage responses are linked to infection outcome of Hantan virus in humans or rodents
Ma, H., Yang, Y., Nie, T., Yan, R., Si, Y., Wei, J., Li, M., Liu, H., Ye, W., Zhang, H., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-44687-4 · Cited by 22 · see citing works
Hartman, A. L., & Myler, P. J. (2023) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiac338 · Cited by 20 · see citing works
Bellomo, C., Alonso, D. O., Ricardo, T., et al. (2021) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0009842 · Cited by 20 · see citing works
“The values are concordant with those found in patients with mild disease in ANDV-HPS at early stages [20].”
ResultSelf-citationIglesias, A., Períolo, N., Bellomo, C., Lewis, L. C., Olivera, C. P., Anselmo, C. R., García, M., Coelho, R. M., Alonso, D. O., Dighero-Kemp, B., et al. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2021.103765 · Cited by 18 · see citing works
Self-citationAchievement and Challenges in Orthohantavirus Vaccines
Chai, S., Wang, L., Du, H., & Jiang, H. X. (2025) · Vaccines · doi:10.3390/vaccines13020198 · Cited by 19 · see citing works
“Human-to-human transmission of Andes virus (ANDV) has been documented [10–13], although this mode of transmission lacks widespread consensus [14].”
de Thoisy, B., Gräf, T., Mansur, D. S., Delfraro, A., & dos Santos, C. N. D. (2024) · Annual Review of Virology · doi:10.1146/annurev-virology-100422-024648 · Cited by 18 · see citing works
Presence and Persistence of Andes Virus RNA in Human Semen
Züst, R., Ackermann‐Gäumann, R., Liechti, N., et al. (2023) · Viruses · doi:10.3390/v15112266 · Cited by 16 · see citing works
“The inhalation of droplets or aerosolized virions are the most likely routes of infection [42].”
BackgroundAndes Hantavirus Outbreak on a Cruise Ship, 2026
Andes Virus Outbreak Working Group (2026) · New England Journal of Medicine · doi:10.1056/nejmc2606496 · Cited by 15 · see citing works
“Further epidemiological analysis is needed to decipher if this is a single or a limited number of zoonotic spillover events, or human-to-human transmission, as was seen in the 2018 outbreak, with similar clustering and lack of diversity 5 .”
Tscherne, A., Guardado‐Calvo, P., Clark, J. J., Krause, R., & Krammer, F. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1575112 · Cited by 24 · see citing works
Bellomo, C., Alonso, D. O., Pérez‐Sautu, U., Prieto, K., Kehl, S., Coelho, R. M., Períolo, N., Paola, N. D., Gerpe, N. M. F., Kuhn, J. H., et al. (2023) · mSphere · doi:10.1128/msphere.00018-23 · Cited by 19 · see citing works
“ANDV/CHI-9717869 and ANDV/CHI-7913 differ in the NSs ORF in five amino-acid positions (5, 20, 33, 35, and 37; Table 2 and 3).”
BackgroundMethodInfluentialSelf-citationNilsson-Payant, B. E., Dafi, R. F., Krüger, S., Rosenthal, M., Tödt, D., Addo, M. M., Steinmann, E., & Meister, T. L. (2025) · Journal of Hospital Infection · doi:10.1016/j.jhin.2025.08.010 · Cited by 14 · see citing works
Jeyachandran, A. V., Irudayam, J. I., Dubey, S., Chakravarty, N., Δάσκου, Μ., Zaiss, A. K., Garcia, G., Konda, B. M., Shah, A., Venkatraman, A., et al. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1013401 · Cited by 18 · see citing works
“One study tracking the ANDV outbreak in Epuyén, Argentina, reported that the median reproductive number when ANDV spread was left uncurbed was 2.12 new cases per infected person, but was reduced to 0.93 when infection control measures were implemented [14].”
InfluentialOrthohantaviruses: An Overview of the Current Status of Diagnostics and Surveillance
Romeo, M. A., Tofani, S., Lapa, D., Mija, C., Maggi, F., Scicluna, M. T., & Nardini, R. (2025) · Viruses · doi:10.3390/v17050622 · Cited by 18 · see citing works
High-resolution in situ structures of hantavirus glycoprotein tetramers
Guo, L., McFadden, E., Slough, M. M., Stone, E. T., Berrigan, J. L., Mittler, E., Hatzakis, K., Hinkley, T. C., Kain, H. S., Ke, Z., et al. (2026) · Cell · doi:10.1016/j.cell.2026.01.030 · Cited by 19 · see citing works
Coelho, R. M., Kehl, S., Períolo, N., et al. (2025) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0013205 · Cited by 12 · see citing works
“Bioinformatic analysis was performed as described previously [8].”
InfluentialSelf-citationWhitmer, S. L. M., Whitesell, A. N., Mobley, M., et al. (2024) · The Lancet Regional Health - Americas · doi:10.1016/j.lana.2024.100836 · Cited by 12 · see citing works
López, W., Altamiranda‐Saavedra, M., Kehl, S., et al. (2023) · BMC Public Health · doi:10.1186/s12889-023-16071-2 · Cited by 12 · see citing works
Self-citationOrthohantavirus infections in South America: a systematic review and meta-analysis
Oloris, S. C. S., Neves, V. F., Iani, F. C. D. M., & Scarponi, C. F. D. O. (2024) · Archives of Virology · doi:10.1007/s00705-024-06104-5 · Cited by 12 · see citing works
“A recent systematic review, including 22 studies did not support the claim of person-to-person transmission of Andes virus (ANDV) [2, 3].”
Mathematical Model of the Spread of Hantavirus Infection
Gutiérrez-Jara, J. P., Muñoz-Quezada, M. T., Córdova‐Lepe, F., & Silva-Guzmán, A. (2023) · Pathogens · doi:10.3390/pathogens12091147 · Cited by 11 · see citing works
Hägele, S., Nußhag, C., Müller, A., et al. (2021) · Virology Journal · doi:10.1186/s12985-021-01636-7 · Cited by 11 · see citing works
Orthohantavirus rodent hosts and genotypes in Southern South America: A narrative review
Ortiz, N., Pinotti, J. D., Andreo, V., González‐Ittig, R. E., & Gardenal, C. N. (2025) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0013489 · Cited by 10 · see citing works
“It has also been proposed as capable of person-to-person transmission, although this remains a subject of debate [66,76,111–113].”
Lethal hantavirus at sea: Infectious disease outbreaks on cruise ships and limits of preparedness
Zumla, A. I., McCloskey, B., Ippolito, G., et al. (2026) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2026.102989 · Cited by 9 · see citing works
Hantavirus: What you need to know
Lang, K. (2026) · BMJ · doi:10.1136/bmj.s877 · Cited by 9 · see citing works
Ebola Virus Disease: Uniquely Challenging Among the Viral Hemorrhagic Fevers
Matson, M. J., Chertow, D. S., & Munster, V. J. (2025) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaf464 · Cited by 9 · see citing works
“Current evidence suggests that the Andes virus is unique within the family Hantaviridae in its ability to subsequently transmit directly from human to human following zoonotic spillover [61, 62].”
Brocato, R. L., Wu, H., Kwilas, S. A., et al. (2024) · mBio · doi:10.1128/mbio.01600-24 · Cited by 9 · see citing works
“This could limit the impact of lethal hantavirus outbreaks like the one in Yosemite in 2012 (48), Chubut province, Argentina, in 2019 (4), or at military training areas in South Korea (49).”
Orthohantavirus Replication in the Context of Innate Immunity
LaPointe, A. T., Gale, M., & Kell, A. M. (2023) · Viruses · doi:10.3390/v15051130 · Cited by 10 · see citing works
Andes Hantavirus Outbreak on a Cruise Ship, 2026
Andes Virus Outbreak Working Group (2026) · NEJM Evidence · doi:10.1056/evidpha2600170 · Cited by 8 · see citing works
Mora-Rillo, M., Nitin, G., Gkrania-Klotsas, E., Drexler, J. F., Jokelainen, P., Tsiodras, S., Pellejero-Sagastizábal, G., Barac, A. M., Pano-Pardo, J.-R., Lescure, F.-X., et al. (2026) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2026.05.016 · Cited by 10 · see citing works
Ferro, I., López, W., Cassinelli, F., et al. (2024) · Pathogens · doi:10.3390/pathogens13090753 · Cited by 8 · see citing works
Self-citationCase Report: Hantavirus Cardiopulmonary Syndrome Diagnostic in the Face of the COVID-19 Pandemic
de Lemos, E. R. S., Fernandes, J., Coelho, T. A., et al. (2022) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.21-0637 · Cited by 8 · see citing works
Hantavirus outbreak on a cruise ship in the South Atlantic
Islam, M. D. F., Chughtai, A. A., Wood, J., et al. (2026) · The Lancet · doi:10.1016/s0140-6736(26)00934-7 · Cited by 7 · see citing works
The Era of Gene Therapy: The Advancement of Lentiviral Vectors and Their Pseudotyping
Jargalsaikhan, B.-E., Muto, M., & Ema, M. (2025) · Viruses · doi:10.3390/v17081036 · Cited by 10 · see citing works
“Regarding viruses belonging to the Bunyavirales order, some cause zoonotic diseases; such as Rift Valley Fever Virus (RVFV) from the Phenuiviridae family, Crimean-Congo Hemorrhagic Fever Virus (CCHFV) from the Nairoviridae family, and Andes virus (ANDV) from the Hantaviridae family [284–286].”
Seoul orthohantavirus evades innate immune activation by reservoir endothelial cells
Klimaj, S. D., LaPointe, A. T., Martinez, K., Acosta, E. H., & Kell, A. M. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012728 · Cited by 10 · see citing works
“Importantly, humans are a dead-end host for hantaviruses, with extremely rare exceptions for Andes orthohantavirus, and the antiviral response can be effective for viral clearance in survivors and fatal victims of hantavirus infection [39–42].”
Zoonotic Hantaviridae with global public health significancePreprint
Chen, J., Chen, R.-X., Gong, H., et al. (2023) · doi:10.22541/au.168606259.94645566/v1 · Cited by 7 · see citing works
Insight into the Hantaan virus RNA-dependent RNA polymerase inhibition using in-silico approaches
Faisal, S., Badshah, S. L., Sharaf, M., et al. (2022) · Molecular Diversity · doi:10.1007/s11030-022-10567-6 · Cited by 7 · see citing works
“These include transfer via aerosolization of rodent excretory waste [5], person-to-person transmission was also reported in Argentina in 2020 [6], and transmission through transfusion of infected blood is also possible [7].”
BackgroundHuman-to-Human Transmission of Andes Virus Modeled in Syrian Hamster
Riesle‐Sbarbaro, S. A., Kirchoff, N., Hansen-Kant, K., et al. (2023) · Emerging infectious diseases · doi:10.3201/eid2910.230544 · Cited by 6 · see citing works
“Reports of human-to-human ANDV transmission in recent decades ( 3 – 5 ), which could be driven by specific mutations of ANDV ( 12 ), highlight the importance of this phenomenon.”
Hantavirus Pulmonary Syndrome in a COVID-19 Patient, Argentina, 2020
Coelho, R. M., Períolo, N., Duhalde, C. P., Alonso, D. O., Bellomo, C., Corazza, M. S., Iglesias, A., & Martínez, V. P. (2022) · Emerging infectious diseases · doi:10.3201/eid2804.211837 · Cited by 6 · see citing works
Self-citationvan den Berg, O. E., UKHSA ANDV Team, Severi, E., et al. (2026) · Eurosurveillance · doi:10.2807/1560-7917.es.2026.31.24.2600477 · Cited by 5 · see citing works
“The causative ANDV was closely related to the ANDV that caused person-to-person transmission in the Epuyén, Argentina outbreak in 2018 [16].”
Hantavirus Gn H Nanoparticle Immunogen Elicits a Cross-Neutralizing Antibody Response in Mice
Ramos, K. E., Mariano, M. C., Mittler, E., Pardo, R., Zylberman, V., Guardado‐Calvo, P., Chandran, K., & Lai, J. R. (2025) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5c00415 · Cited by 6 · see citing works
High genomic stability of Andes virus following successive passage in vivo in Syrian hamsters
Warner, B. M., Prévost, J., Tailor, N., et al. (2025) · Journal of Virology · doi:10.1128/jvi.00512-25 · Cited by 5 · see citing works
“This outbreak spread to 34 individuals and caused 11 deaths, and was thought to have originated from a single individual infected via a rodent reservoir (6).”
Alonso, D. O., Kehl, S., Coelho, R. M., Períolo, N., Poklépovich, T., Loria, J. S., Cuba, F., Pérez‐Sautu, U., Sánchez-Lockhart, M., Palacios, G. F., et al. (2024) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0012465 · Cited by 8 · see citing works
“Most of the S-and M-segments were obtained by bait enrichment as previously described [10] An amplicon based method was implemented for the L-segment and for those cases from which full S-and M-segments were not successfully obtained by bait enrichment technique (S1 Fig).”
Self-citationCintrón, R., Whitmer, S. L. M., Moscoso, E., Campbell, E. M., Kelly, R. J., Talundzic, E., Mobley, M., Chiu, K. W., Shedroff, E., Shankar, A., et al. (2023) · Viruses · doi:10.3390/v15112208 · Cited by 5 · see citing works
The Input of Structural Vaccinology in the Search for Vaccines against Bunyaviruses
Serris, A. (2021) · Viruses · doi:10.3390/v13091766 · Cited by 5 · see citing works
“However, studies of several outbreaks in Argentina have revealed that at least one New World virus, Andes virus (ANDV), can be transmitted from person to person through inhalation of aerosolized virions [24] and from mother to child through breast milk [25].”
BackgroundTortosa, F. G., Santamaría, G., Bustamante, R., et al. (2026) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(26)00285-9 · Cited by 4 · see citing works
Self-citationGuzzi, P. H., Branda, F., Scarpa, F., Ceccarelli, G., Ciccozzi, M., Giorgi, F. M., & Veltri, P. (2026) · Pathogens · doi:10.3390/pathogens15060601 · Cited by 5 · see citing works
“…infections and 11 deaths, with an estimated reproductive number of R 0 = 2.12 prior to the enforcement of isolation measures, falling to 0.96 thereafter—demonstrating that ANDV can sustain self-amplifying chains of human transmission in the absence of timely public health intervention [10].”
InfluentialHuman infection with Andes hantavirus: an update for the general physician
Durante‐Mangoni, E., Cafarella, I., Mercadante, S., et al. (2026) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2026.106946 · Cited by 4 · see citing works
An unexpected outbreak at sea: revisiting Hantavirus transmission dynamics
Bogacka, A., Pupaibool, J., Genderen, P. J. J., et al. (2026) · Journal of Travel Medicine · doi:10.1093/jtm/taag041 · Cited by 4 · see citing works
Rodriguez-Morales, A. J., Mattar, S., V, Sabogal, I. A. R., Álvarez, C., Porras-Pedroza, B. E., Faccini‐Martínez, Á. A., Chica-Granados, E. T., López-Delgado, D. S., Lucano-Tello, S. A., Escarrá, F., et al. (2026) · New Microbes and New Infections · doi:10.1016/j.nmni.2026.101767 · Cited by 4 · see citing works
“Unlike most hantaviruses, however, Andes virus is the only hantavirus with substantial epidemiological and molecular evidence supporting person-to-person transmission, especially in settings of close, prolonged, household, intimate, caregiving, or crowded contact [14,17,20].”
Self-citationIacobucci, G. (2026) · BMJ · doi:10.1136/bmj.s899 · Cited by 4 · see citing works
Nephropathia Epidemica Caused by Puumala Virus in Bank Voles, Scania, Southern Sweden
Ling, J., Lundeberg, E. E., Wasberg, A., et al. (2024) · Emerging infectious diseases · doi:10.3201/eid3004.231414 · Cited by 4 · see citing works
“However, such possibilities are unlikely; only anecdotal reports on hantavirus-infected birds are available, and hanta-virus transmission is known to be almost exclusively epizootic; just 1 human–human transmission has been reported, caused by Andes virus (ANDV) ( 27 ).”
BackgroundDeep Sequencing to Reveal Phylo-Geographic Relationships of Juquitiba Virus in Paraguay
Nnamani, E. I., Spruill-Harrell, B., Williams, E. P., Taylor, M. K., Owen, R. D., & Jonsson, C. B. (2023) · Viruses · doi:10.3390/v15091798 · Cited by 4 · see citing works
Modeling of hantavirus cardiopulmonary syndrome
Gutiérrez-Jara, J. P., & Muñoz-Quezada, M. T. (2022) · Medwave · doi:10.5867/medwave.2022.03.002526 · Cited by 3 · see citing works
Andes Virus on a Cruise Ship, what it Tells us About the Global Pandemic Preparedness Agenda
Koopmans, M., Bréchot, C., Bruzzone, R., et al. (2026) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2026.101755 · Cited by 3 · see citing works
Self-citationVaccines and therapeutics for Andes hantavirus
Tscherne, A., Halwe, N. J., & Krammer, F. (2026) · npj Viruses · doi:10.1038/s44298-026-00200-w · Cited by 3 · see citing works
Single-dose mRNA vaccines against Andes hantavirus
Meyer, M., Kuzmin, I. V., Dews, E. A., Hyde, M. A., & Bukreyev, A. A. (2026) · The Lancet · doi:10.1016/s0140-6736(26)01124-4 · Cited by 6 · see citing works
The MV Hondius Hantavirus Outbreak—Lessons for Pandemic Preparedness
Hertelendy, A. J., Gostin, L. O., & Ciottone, G. R. (2026) · JAMA · doi:10.1001/jama.2026.10321 · Cited by 3 · see citing works
Hantavirus outbreak should reset WHO’s default approach to airborne risk
Milton, D. K., Greenhalgh, T., Fisman, D. N., Kvalsvig, A., Morawska, L., & Samet, J. M. (2026) · BMJ · doi:10.1136/bmj.s919 · Cited by 3 · see citing works
High-resolution in situ structures of hantavirus glycoprotein tetramersPreprint
Guo, L., McFadden, E., Slough, M. M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.17.660152 · Cited by 3 · see citing works
Ying, Q., Zhang, X., Wang, S., Gu, T., Zhang, J., Feng, W., Li, D., Dong, Y., Wu, X., & Wang, F. (2025) · Journal of Medical Virology · doi:10.1002/jmv.70182 · Cited by 4 · see citing works
Seoul orthohantavirus evades innate immune activation by reservoir endothelial cellsPreprint
Klimaj, S. D., LaPointe, A. T., Martinez, K., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.18.599607 · Cited by 3 · see citing works
Alonso, D. O., Kehl, S., Coelho, R. M., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.25.586579 · Cited by 3 · see citing works
“Bioinformatic analysis on fastQ resulting files were performed as previously described Martinez et al 2020 supplementary material.”
BackgroundMethodSelf-citationLes Orthohantavirus du Nouveau Monde
Gourjault, C., Matheus, S., Turnier, P. L., et al. (2023) · Médecine et Maladies Infectieuses Formation · doi:10.1016/j.mmifmc.2023.09.004 · Cited by 3 · see citing works
Fahlevi, M., Leonita, L., & Aries (2022) · 2022 4th International Conference on Cybernetics and Intelligent System (ICORIS) · doi:10.1109/icoris56080.2022.10031371 · Cited by 3 · see citing works
“The results of clinical analysis of the virus show person-to-person transmission [9], [10].”
BackgroundIs COVID-19 Herd Immunity Influenced by Population Densities of Cities?
Arbel, Y., Arbel, Y., Kerner, A., & Kerner, M. (2022) · Sustainability · doi:10.3390/su141610286 · Cited by 3 · see citing works
Engdahl, T. B., Binshtein, E., Brocato, R. L., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.19.500579 · Cited by 3 · see citing works
Ramos, H., Díaz-Gavidia, C., Fuentes-Luppichini, E., Díaz, M., Pradenas, J., Rogers, C., Pino, K., Henríquez, C., Martínez-Valdebenito, C., Marcela Ferrés, G., et al. (2026) · The Lancet Microbe · doi:10.1016/j.lanmic.2026.101454 · Cited by 2 · see citing works
Hantavirus on the rise: clinical, virological, immunological, and public health perspectives
Acharya, A., Murakonda, S. P., Sutar, D., & Byrareddy, S. N. (2026) · Current Opinion in Immunology · doi:10.1016/j.coi.2026.102804 · Cited by 2 · see citing works
Andes virus on a cruise ship: person-to-person transmission and an empty pipeline
Mitjà, O. (2026) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(26)00283-5 · Cited by 2 · see citing works
First epidemic of hantavirus on cruise ships: from passenger surveillance to ship ecology
Ceccarelli, G., Branda, F., Ceccarelli, C., Scarpa, F., & Ciccozzi, M. (2026) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2026.2675432 · Cited by 3 · see citing works
“…2, these include pre-embarkation infection, environmentally mediated onboard exposure associated with rodent-contaminated technical or service compartments, and, uniquely in the case of Andes hantavirus, human-to-human transmission occurring under conditions of close and prolonged contact [18].”
Hantavirus disease and the need for pathogenesis-guided therapy
Paludan, S. R., & Cherry, S. R. (2026) · The Journal of Experimental Medicine · doi:10.1084/jem.20260871 · Cited by 2 · see citing works
Song, J.-N., Chen, D., Wang, L., & Jiang, H. X. (2025) · Infectious Diseases & Immunity · doi:10.1097/id9.0000000000000187 · Cited by 3 · see citing works
“[84,85] However, in 2022, a review article collected thousands of records concerning human-to-human transmission of Andes virus, and ultimately demonstrated that the evidence to date does not support the existence of human-to-human transmission of Hantavirus.”
A pan-orthohantavirus human lung xenograft mouse model and its utility for preclinical studies
Rissmann, M., Noack, D., Spliethof, T. M., et al. (2025) · PLoS Pathogens · doi:10.1371/journal.ppat.1012875 · Cited by 2 · see citing works
Goodfellow, S. M., Nofchissey, R. A., Morley, V. J., et al. (2024) · npj Viruses · doi:10.1038/s44298-024-00016-6 · Cited by 2 · see citing works
Self-citationHantaviruses in a Global Perspective
Krautkrämer, E., Peintner, L., & Essbauer, S. S. (2023) · Springer eBooks · doi:10.1007/978-3-031-27164-9_30 · Cited by 2 · see citing works
Bellomo, C., Alonso, D. O., Ricardo, T., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.13.448262 · Cited by 2 · see citing works
Self-citationGenetic depletion studies define receptor usage by virulent hantaviruses in human endothelial cellsPreprint
Dieterle, M. E., Solà-Riera, C., Jangra, R. K., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.30.424861 · Cited by 2 · see citing works
Climate change and the growing threat of bunyaviruses
Bowen, J. M., & Tilston‐Lunel, N. L. (2026) · Journal of Virology · doi:10.1128/jvi.01772-25 · Cited by 1 · see citing works
“Consequently, climatic changes that reshape vector habitats and transmission networks have the potential not only to expand the geographic range of bunyaviruses but also to influence their evolutionary dynamics (19).”
- Authors
- Martínez, V. P., Di Paola, N., Alonso, D. O., Pérez-Sautu, U., Bellomo, C. M., Iglesias, A. A., Coelho, R. M., López, B., Periolo, N., Larson, P. A., Nagle, E. R., Chitty, J. A., Pratt, C. B., Díaz, J., Cisterna, D., Campos, J., Sharma, H., Dighero-Kemp, B., Biondo, E., Lewis, L., Anselmo, C., Olivera, C. P., Pontoriero, F., Lavarra, E., Kuhn, J. H., Strella, T., Edelstein, A., Burgos, M. I., Kaler, M., Rubinstein, A., Kugelman, J. R., Sanchez-Lockhart, M., Perandones, C., & Palacios, G.
- Affiliations
- Administración Nacional de Laboratorios e Institutos de Salud (AR)
- From Laboratorio Nacional de Referencia de Hantavirus (V.P.M., D.O.A., C.M.B., A.A.I., R.M.C., N.P.) and Plataforma Genomica (B.L., D.C., J.C.), Instituto Nacional de Enfermedades Infecciosas, and Unidad Operativa Centro de Contención Biológica (A.E.), Administración Nacional de Laboratorios e Institutos de Salud Dr. Carlos G. Malbrán (C.P.), Secretaría de Gobierno de Salud (M.I.B., M.K., A.R.), Área Programática Esquel (J.D., E.B.), and Hospital Zonal de Esquel (L.L., C.A., C.P.O., E.L.),...
- United States Army Medical Research Institute of Infectious Diseases (US)
- National Institutes of Health (US)
- Ministerio de Salud (AR)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2020-12-03
- Volume
- 383
- Issue
- 23
- Pages
- 2230-2241
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W3108547826
- Cited by
- 247
- References
- 37
- Citations by year
- 2026: 156 · 2025: 23 · 2024: 19 · 2023: 24 · 2022: 13 · 2021: 12
- FWCI
- 1.61
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- CONICET Digital (CONICET) (submittedVersion, cc-by-nc-sa)
- Funders
- Administración Nacional de Laboratorios e Institutos de Salud (ANLIS), Dr. Carlos Malbrán
- Medical Chemical and Biological Incident Preparedness and Response Funding
- US National Institute of Allergy and Infectious Diseases (HHSN272200700016I)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Vectors
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Outbreaks Research
- Keywords
- Andes virus, hantavirus pulmonary syndrome, human-to-human transmission, superspreaders, outbreak investigation, reproduction number, viral load, liver injury, rodent reservoirs, social gatherings, quarantine and isolation, Chubut, genome sequencing, serologic testing, contact tracing
- MeSH terms
- Adolescent, Adult, Animals, Argentina, Blood Chemical Analysis, Carrier State, Disease Outbreaks, Female, Orthohantavirus, Humans, Male, Middle Aged, Phylogeny, Rodentia, Hantavirus Pulmonary Syndrome, Viral Load, Young Adult, High-Throughput Nucleotide Sequencing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-11.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-11.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review